Discover 330 paid clinical trials in Mississippi. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Mississippi provides diverse clinical research opportunities, opening doors for healthy volunteers interested in paid studies, as well as people with specific health conditions to contribute to medical research. Research hubs in Jackson, Gulfport, and Hattiesburg are actively recruiting, granting participants access to innovative treatments and comprehensive care.
Filter
1
Filter results
Results: 330
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: East Greenwich RI, Morehead City NC, Hampton VA,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea
for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: East Greenwich RI, Hampton VA, New Bern NC,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Diabetic Nerve Pain Study of a Non-Opioid Medication for Adults With Ongoing Foot and Leg Pain
for
Diabetic Neuropathies
Location: East Greenwich RI, East Syracuse NY, Washington DC,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
COPD, Emphysema, and Chronic Bronchitis Studies for Current or Former Smokers
for
Pulmonary Disease, Chronic Obstructive
Location: Morehead City NC, Suffolk VA, Binghamton NY, Potomac MD,
Sex: All
Age: 40 - 70+
Recruiting
FeaturedActive & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Boston MA, Providence RI, North Massapequa NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, c-MET
Location: Levis, Greenfield Park, Montreal, Brampton,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04928846
Phase 3, Recruiting
Featured
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Providence RI, North Worcester MA, Lebanon NH,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase 3, Recruiting
Featured
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
for
Crohn's Disease, Ulcerative Colitis
Location: New Bedford MA, Providence RI, Quebec, New York NY,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07697456
Phase 2, Recruiting
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Boston MA, Needham MA, New Haven CT, Quebec,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase 3, Recruiting
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Quebec, Sherbrooke, Montreal, Morehead City NC,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351058
Phase 3, Recruiting
Featured
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Providence RI, New Haven CT, Lebanon NH, Bay Shore NY,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase 2, Recruiting
Featured
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Nashua NH, Philadelphia PA, Miami FL, Weston FL,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase 3, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Nashua NH, Stamford CT, Morristown NJ, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Location: Burlington MA, East Greenwich RI, Carmel NY,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06318169
Phase 3, Recruiting
Featured
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
for
Episodic Migraine
Location: Morristown NJ, Philadelphia PA, Franklin VA, Miami FL,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05711394
Phase 3, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH